Literature DB >> 7975570

Headache.

N H Raskin1.   

Abstract

Headache-prone patients have many highly effective therapeutic options open to them. Used only at the time of headache, sumatriptan succinate by mouth or injection and dihydroergotamine nasal spray are novel choices now or soon to be available. The original migraine therapy, ergotamine, is highly effective in its rectal suppository formulation, when used at a subnauseating dosage. Valproate sodium is the latest addition to the many therapies available for long-term stabilization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7975570      PMCID: PMC1011413     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  39 in total

1.  Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.

Authors:  J Jones; D Sklar; J Dougherty; W White
Journal:  JAMA       Date:  1989-02-24       Impact factor: 56.272

2.  Analgesic-induced chronic headache: long-term results of withdrawal therapy.

Authors:  H C Diener; J Dichgans; E Scholz; S Geiselhart; W D Gerber; A Bille
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

3.  Pharmacological actions of the main metabolites of dihydroergotamine.

Authors:  E Müller-Schweinitzer
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Interval therapy of migraine: long-term results.

Authors:  N H Raskin; R K Schwartz
Journal:  Headache       Date:  1980-11       Impact factor: 5.887

5.  Long-term study of propranolol in the treatment of migraine.

Authors:  S Diamond; L Kudrow; J Stevens; D B Shapiro
Journal:  Headache       Date:  1982-11       Impact factor: 5.887

Review 6.  Clinical pharmacokinetics of ergotamine in migraine and cluster headache.

Authors:  V L Perrin
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

7.  Possible role of central serotoninergic neurons in the development of dental pain and aspirin-induced analgesia in the monkey.

Authors:  K W Shyu; M T Lin; T C Wu
Journal:  Exp Neurol       Date:  1984-04       Impact factor: 5.330

8.  Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.

Authors:  R A Tokola; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

9.  Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses.

Authors:  Y O Taiwo; J D Levine
Journal:  J Neurosci       Date:  1988-04       Impact factor: 6.167

10.  Disposition of sumatriptan in laboratory animals and humans.

Authors:  C M Dixon; D A Saynor; P D Andrew; J Oxford; A Bradbury; M H Tarbit
Journal:  Drug Metab Dispos       Date:  1993 Sep-Oct       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.